Ignite Creation Date:
2024-05-06 @ 4:32 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05015010
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-10-03
First Post:
2021-08-16
Brief Title:
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
Sponsor:
Gruppo Oncologico Italiano di Ricerca Clinica
Organization:
Gruppo Oncologico Italiano di Ricerca Clinica
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-16
First Submit QC Date:
August 16 2021
Study First Post Date:
2021-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-07
Last Update Post Date:
2022-10-03
Last Update Post Date Type:
ACTUAL